In obese people, higher irisin levels may be the result of greater irisin production in the more developed adipose and muscle tissue or may reflect a compensatory increase in irisin levels to combat obesity and metabolic syndrome to overcome irisin resistance, just as elevated insulin and leptin levels occur in patients with insulin and leptin resistance. The gene discussed is FNDC5; the disease is obesity disorder.